Although results of the study were disappointing, in this video blog, Dr. Maurie Markman notes that this international consortium represents an impressive mechanism for accrual to important trials. Medscape Hematology-Oncology
An experimental peptide vaccine produced an immunologic response in more than half of study participants and was associated with longer event-free survival and periods of remission. Medscape Medical News
A new study adds to conflicting data on the use of ovarian suppression during chemotherapy in premenopausal women with breast cancer. Medscape Medical News
A large Israeli study confirms that, among patients with ovarian cancer, carrying the BRCA1/2 mutation confers a survival advantage. Medscape Medical News
Compared with radiotherapy alone, the combination of chemotherapy plus radiotherapy improves overall and disease-free survival in patients with cervical cancer. Medscape Medical News